There is 1 version of this bill. View text

Click the check-box to add or remove the section, click the text link to scroll to that section.
Titles Actions Overview All Actions Cosponsors Committees Related Bills Subjects Latest Summary All Summaries

Titles (2)

Short Titles

Short Titles - House of Representatives

Short Titles as Introduced

Cosmetic Modernization Amendments of 2015

Official Titles

Official Titles - House of Representatives

Official Title as Introduced

To amend the Federal Food, Drug, and Cosmetic Act to establish new procedures and requirements for the registration of cosmetic manufacturing establishments, the submission of cosmetic and ingredient statements, and the reporting of serious cosmetic adverse events, and for other purposes.

Actions Overview (1)

Date Actions Overview
11/18/2015Introduced in House

All Actions (3)

Date All Actions
11/20/2015Referred to the Subcommittee on Health.
Action By: Committee on Energy and Commerce
11/18/2015Referred to the House Committee on Energy and Commerce.
Action By: House of Representatives
11/18/2015Introduced in House
Action By: House of Representatives

Cosponsors (2)

* = Original cosponsor
CosponsorDate Cosponsored
Rep. Flores, Bill [R-TX-17] 12/02/2015
Rep. Johnson, Eddie Bernice [D-TX-30] 03/14/2016

Committees (1)

Committees, subcommittees and links to reports associated with this bill are listed here, as well as the nature and date of committee activity and Congressional report number.

Committee / Subcommittee Date Activity Reports
House Energy and Commerce11/18/2015 Referred to
House Energy and Commerce Subcommittee on Health11/20/2015 Referred to

No related bill information was received for H.R.4075.

Latest Summary (1)

There is one summary for H.R.4075. View summaries

Shown Here:
Introduced in House (11/18/2015)

Cosmetic Modernization Amendments of 2015

This bill amends the Federal Food, Drug, and Cosmetic Act to set forth provisions governing the Food and Drug Administration's (FDA's) regulation of cosmetics, including requiring the registration of manufacturing establishments and the submission of a cosmetic and ingredient statement for each cosmetic. The FDA must publish a list of registered establishments and a list of cosmetics and their ingredients.

Cosmetic manufacturers, packers, and distributors must report to the FDA any serious and unexpected adverse events likely caused by a cosmetic. Cosmetic labels must include contact information to report a serious adverse event.

The FDA may establish principles and standards for good manufacturing practices for cosmetics. A cosmetic may not be sold if it presents a significant risk of serious adverse health consequences because it was not manufactured in accordance with good manufacturing practices.

Certain ingredients are deemed safe for use in cosmetics unless restricted by the FDA. The FDA must establish a program to evaluate the safety of cosmetics and cosmetic ingredients.

The FDA must establish and maintain a National Cosmetic Regulatory Databank that contains submitted information on cosmetics. Confidential business and trade secret information may be disclosed only to state agencies that request this information for good cause.

The FDA may establish exemptions to requirements so that implementation and compliance is cost-effective.

Color additives that the FDA has not listed as suitable and safe but that are generally recognized as safe may be used in cosmetics.

States and local governments may not establish or continue in effect specified requirements relating to cosmetics.

Cosmetics may only be imported from registered establishments that have submitted a cosmetic and ingredient statement.